HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
26 hedge funds and large institutions have $2.2M invested in Hepion Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
+1
Holders Change %
+4%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
8
Reduced
8
Closed
1
Calls
$52K
Puts
$1K
Net Calls
+$51K
Net Calls Change
-$38K
Top Buyers
Top Sellers
1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$20.7K |
2 |
Bank of New York Mellon
New York
|
-$20.7K |
3 |
PAM
PVG Asset Management
Golden,
Colorado
|
-$14.2K |
4 |
VF
Virtu Financial
New York
|
-$13.4K |
5 |
Citadel Advisors
Miami,
Florida
|
-$5.79K |